GZ17-6.02 Inhibits the Growth of EGFRvIII+ Glioblastoma
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms23084174
Abstract: Epidermal Growth Factor Receptor (EGFR) is amplified in over 50% of glioblastomas and promotes tumor formation and progression. However, attempts to treat glioblastoma with EGFR tyrosine kinase inhibitors have been unsuccessful thus far. The current… read more here.
Keywords: growth; gz17; inhibits growth; gz17 inhibits ... See more keywords